Researchers at Texas Children’s Cancer Center and the Center for Cell and Gene Therapy at Baylor College of Medicine, Texas Children’s Hospital and Houston Methodist have published results of a Phase I clinical trial of a novel immunotherapy for high-risk sarcomas in the journal Nature Cancer.
Medical Xpress – latest medical and health news stories
